Ftse Mib
32.665,21
-2,81%
DAX
18.002,02
-1,43%
S&P 500
5.431,60
-0,04%
NASDAQ
17.688,88
0,12%
Bitcoin
65.992,56
-0,02%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Gilead Sciences Inc (GILD) Gilead Sciences Inc (GILD) Notizie

Gilead Sciences Inc

GILD
65,27
1,71 (2,69%)
15 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
14/6/202409:00BWNew Kite Clinical Research and Real-World Evidence for..
12/6/202401:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202401:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202401:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202401:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202401:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202401:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202410:30BWGilead Announces New England Journal of Medicine Publication..
05/6/202408:00BWGilead’s Seladelpar Demonstrated a Sustained and Consistent..
03/6/202416:00BWKite’s Tecartus® Demonstrates Sustained Overall Survival in..
03/6/202415:00BWEncouraging New Data Presented on Kite’s Yescarta® for..
02/6/202414:00BWGilead and Arcus Announce Etrumadenant Plus Zimberelimab..
01/6/202414:00BWGilead and Arcus Announce Anti-TIGIT Domvanalimab Plus..
31/5/202414:07BWEVOKE-01 Study Results in Metastatic NSCLC to Be Presented..
30/5/202422:45BWGilead Provides Update on Phase 3 TROPiCS-04 Study
22/5/202414:30BWGilead to Present Latest Research Across Key Liver Disease..
18/5/202414:30BWInvestigational Seladelpar Demonstrates Significant..
14/5/202416:09BWKite Data at EHA 2024 Demonstrate Positive Patient Outcomes..
09/5/202423:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202423:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202423:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202423:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202423:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202422:11EDGAR2Form 8-K - Current report
09/5/202422:05BWKite and Arcellx Continue Momentum with Advances in..
09/5/202421:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202421:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/5/202422:58EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202414:30BWGilead and Kite Oncology to Highlight Broad and Diverse..
30/4/202422:05BWGilead Sciences to Present at Upcoming Investor Conferences
26/4/202414:00BWFDA Approves Biktarvy® Label Update With Data for Pregnant..
26/4/202413:47IHMARKETNEWSExxon Mobil Net Profit Drops 28% to $8.22 Billion, Atlassian..
25/4/202422:02BWGilead Sciences Announces First Quarter 2024 Financial..
25/4/202413:53IHMARKETNEWSU.S. Futures Drop in Pre-Market Trading as Tech Stocks..
08/4/202422:05BWGilead Sciences to Release First Quarter 2024 Financial..
28/3/202413:30BWFDA Expands Indication for Gilead's Vemlidy (Tenofovir..
28/3/202412:00GLOBEGilead and Xilio Announce Exclusive License Agreement for..
22/3/202414:18BWGilead Sciences Announces Completion of Acquisition of..
19/3/202400:29BWCenter for Disease Analysis Foundation Announces First Round..
11/3/202413:34EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
11/3/202413:24BWGilead Sciences Announces Expiration of Hart-Scott-Rodino..
06/3/202422:30BWBiktarvy® Demonstrates High Rates of Viral Suppression in..
06/3/202416:25BWGilead and Merck Announce Phase 2 Data Showing an..
06/3/202414:00BWGilead and Merus Announce Collaboration to Discover Novel..
05/3/202422:35BWNew Real-World Data Further Support the Use of Veklury®..
05/3/202422:30BWGilead’s Innovative HIV Treatment Research Pipeline Aims to..
01/3/202400:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202422:49EDGAR2Form 144 - Report of proposed sale of securities
28/2/202422:38EDGAR2Form 144 - Report of proposed sale of securities
Apertura: 62,75 Min: 62,71 Max: 65,62
Chiusura: 63,56

La tua Cronologia

NASDAQ
GILD
Gilead Sciences
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network